4-(1-(5-(4-(2-chlorophenyl)piperazin-1-yl)pentyl)-1H-indol-3-yl)butanoic acid

ID: ALA4788144

PubChem CID: 156767234

Max Phase: Preclinical

Molecular Formula: C27H34ClN3O2

Molecular Weight: 468.04

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12

Standard InChI:  InChI=1S/C27H34ClN3O2/c28-24-11-3-5-13-26(24)30-19-17-29(18-20-30)15-6-1-7-16-31-21-22(9-8-14-27(32)33)23-10-2-4-12-25(23)31/h2-5,10-13,21H,1,6-9,14-20H2,(H,32,33)

Standard InChI Key:  SADGWXRWSBZIIA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   13.6273  -19.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6262  -20.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3409  -20.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3392  -19.1450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0546  -19.5541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0548  -20.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8409  -20.6358    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3265  -19.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8405  -19.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0960  -21.4203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9030  -21.5916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0951  -18.5138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9020  -18.3421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1567  -17.5574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9635  -17.3856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2182  -16.6009    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5158  -17.9985    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.4549  -20.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2619  -21.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5171  -21.9341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3241  -22.1054    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5792  -22.8899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8759  -21.4921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6829  -21.6635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9380  -22.4480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7450  -22.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3862  -23.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9971  -23.4026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8032  -23.5740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3560  -22.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0970  -22.1727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2915  -22.0050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0324  -21.2217    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 11 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 22 27  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 26  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4788144

    ---

Associated Targets(Human)

ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.04Molecular Weight (Monoisotopic): 467.2340AlogP: 5.69#Rotatable Bonds: 11
Polar Surface Area: 48.71Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.45CX Basic pKa: 7.67CX LogP: 3.58CX LogD: 3.44
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.37Np Likeness Score: -1.18

References

1. Zeng LY,Yang F,Chen K,Zeng Y,Jiang Z,Liu S,Xi B.  (2020)  The one-pot synthesis of butyl-1H-indol-3-alkylcarboxylic acid derivatives in ionic liquid as potent dual-acting agent for management of BPH.,  205  [PMID:32949920] [10.1016/j.ejmech.2020.112616]

Source